CLINICAL_TRIALS
withdrawal
· 2019-02-21
Clinical Trial Update: Assessment of Prevident Sodium Fluoride 1.1% Toothpaste Using an Intra-oral Remineralization-demineralization Model [Phase 2]
Summary
Phase 2 trial of Prevident Sodium Fluoride 1.1% toothpaste was withdrawn (status change) after evaluation in an intra-oral remineralization-demineralization mod…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Colgate Palmolive | Conditions: Dental Caries | Phase 2 | Status: WITHDRAWN